<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33113244</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0461</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>35</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biochemical and molecular toxicology</Title>
          <ISOAbbreviation>J Biochem Mol Toxicol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>SP3 is associated with migration, invasion, and Akt/PKB signalling in MDA-MB-231 breast cancer cells.</ArticleTitle>
        <Pagination>
          <StartPage>e22657</StartPage>
          <MedlinePgn>e22657</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jbt.22657</ELocationID>
        <Abstract>
          <AbstractText>Specificity proteins (SPs) have pro-oncogenic functions in cancer cells, ranging from cancer cell proliferation, migration, invasion, and angiogenesis. There is strong evidence that several antineoplastic drugs target depletion of SP proteins via different pathways. However, the mode of action of SP3 and the underlying consequences of its depletion are not well understood. Here, we demonstrate that SP3 is overexpressed in invasive breast cancer cells vs normal counterparts. The gene expression analysis from The Cancer Genome Atlas datasets indicated that SP3 is strongly correlated with Akt signalling-related proteins, G protein subunit alpha 13, and RAB33B (RAB33B, member RAS oncogene family). RNA interference of SP3 decreased active phosphorylation of Akt at serine and threonine sites. These findings indicate that SP3 exhibits a pro-oncogenic function, which clearly fits the description of an nononcogene addiction gene. Future analyses are prompted to uncover the SP3 gene regulation function and to reveal downstream targets of SP3 in breast cancer.</AbstractText>
          <CopyrightInformation>Â© 2020 Wiley Periodicals LLC.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mansour</LastName>
            <ForeName>Mohammed A</ForeName>
            <Initials>MA</Initials>
            <Identifier Source="ORCID">0000-0001-8701-4007</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Human Sciences, School of Applied Sciences, London South Bank University, London, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biochemistry Division, Department of Chemistry, Faculty of Science, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Biochem Mol Toxicol</MedlineTA>
        <NlmUniqueID>9717231</NlmUniqueID>
        <ISSNLinking>1095-6670</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C497121">SP3 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>148710-94-5</RegistryNumber>
          <NameOfSubstance UI="D051705">Sp3 Transcription Factor</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002465" MajorTopicYN="Y">Cell Movement</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051705" MajorTopicYN="N">Sp3 Transcription Factor</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Akt signalling</Keyword>
        <Keyword MajorTopicYN="N">GNA13</Keyword>
        <Keyword MajorTopicYN="N">SP3</Keyword>
        <Keyword MajorTopicYN="N">breast cancer</Keyword>
        <Keyword MajorTopicYN="N">transcription factor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>17</Hour>
          <Minute>19</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33113244</ArticleId>
        <ArticleId IdType="doi">10.1002/jbt.22657</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>D. L. Holliday, V. Speirs, Breast Cancer Res. 2011, 13, 215. https://doi.org/10.1186/bcr2889</Citation>
        </Reference>
        <Reference>
          <Citation>J. Liu, P. Wang, P. Zhang, X. Zhang, H. Du, Q. Liu, B. Huang, C. Qian, S. Zhang, W. Zhu, X. Yang, Y. Xiao, Z. Liu, D. Luo, J. Appl. Genet. 2019, 60, 335. https://doi.org/10.1007/s13353-019-00507-w</Citation>
        </Reference>
        <Reference>
          <Citation>Y. H. Zhou, Y. Liu, W. Zhang, C. Liu, J. J. He, X. J. Tang, Pathol., Res. Pract. 2019, 215, 152644. https://doi.org/10.1016/j.prp.2019.152644</Citation>
        </Reference>
        <Reference>
          <Citation>C. B. Moelans, J. de Ligt, P. van der Groep, P. Prins, N. Besselink, M. Hoogstraat, N. Ter Hoeve, M. Lacle, R. Kornegoor, C. van der Pol, W. de Leng, E. Barbe, B. van der Vegt, J. Martens, P. Bult, V. T. Smits, M. Koudijs, I. Nijman, E. Voest, P. Selenica, B. Weigelt, J. Reis-Filho, E. van der Wall, E. Cuppen, P. J. van Diest, Endocr.-Relat. Cancer 2019, 26, 779. https://doi.org/10.1530/ERC-19-0278</Citation>
        </Reference>
        <Reference>
          <Citation>J. Johnson, D. C. Bessette, J. M. Saunus, C. E. Smart, S. Song, R. L. Johnston, S. Cocciardi, E. N. Rozali, C. N. Johnstone, A. C. Vargas, S. H. Kazakoff, V. C. BioBank, K. K. Khanna, S. R. Lakhani, G. Chenevix-Trench, P. T. Simpson, K. Nones, N. Waddell, F. Al-Ejeh, Breast Cancer Res. Treat. 2018, 170, 179. https://doi.org/10.1007/s10549-018-4719-9</Citation>
        </Reference>
        <Reference>
          <Citation>J. Greshock, K. E. Bachman, Y. Y. Degenhardt, J. Jing, Y. H. Wen, S. Eastman, E. McNeil, C. Moy, R. Wegrzyn, K. Auger, M. A. Hardwicke, R. Wooster, Cancer Res. 2010, 70, 3677. https://doi.org/10.1158/0008-5472.CAN-09-3788</Citation>
        </Reference>
        <Reference>
          <Citation>S. Safe, J. Abbruzzese, M. Abdelrahim, E. Hedrick, Cancer Prev. Res. 2018, 11, 371. https://doi.org/10.1158/1940-6207.CAPR-17-0407</Citation>
        </Reference>
        <Reference>
          <Citation>M. Marin, A. Karis, P. Visser, F. Grosveld, S. Philipsen, Cell 1997, 89, 619. https://doi.org/10.1016/s0092-8674(00)80243-3</Citation>
        </Reference>
        <Reference>
          <Citation>C. Vizcaino, S. Mansilla, J. Portugal, Pharmacol. Ther. 2015, 152, 111. https://doi.org/10.1016/j.pharmthera.2015.05.008</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Huang, L. Huang, S. Shen, J. Li, H. Lu, W. Mo, Y. Dang, D. Luo, G. Chen, Z. Feng, Oncol. Rep. 2015, 34, 2403. https://doi.org/10.3892/or.2015.4259</Citation>
        </Reference>
        <Reference>
          <Citation>E. Hedrick, Y. Cheng, U. H. Jin, K. Kim, S. Safe, Oncotarget 2016, 7, 22245. https://doi.org/10.18632/oncotarget.7925</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Cheng, P. Imanirad, I. Jutooru, E. Hedrick, U. H. Jin, A. Rodrigues Hoffman, J. Leal de Araujo, B. Morpurgo, A. Golovko, S. Safe, PLoS One 2018, 13, e0192264. https://doi.org/10.1371/journal.pone.0192264</Citation>
        </Reference>
        <Reference>
          <Citation>L. Li, J. R. Davie, Ann. Anat. 2010, 192, 275. https://doi.org/10.1016/j.aanat.2010.07.010</Citation>
        </Reference>
        <Reference>
          <Citation>A. Sapetschnig, F. Koch, G. Rischitor, T. Mennenga, G. Suske, J. Biol. Chem. 2004, 279, 42095. https://doi.org/10.1074/jbc.M404989200</Citation>
        </Reference>
        <Reference>
          <Citation>X. X. Wang, G. C. Guo, X. K. Qian, D. W. Dou, Z. Zhang, X. D. Xu, X. Duan, X. H. Pei, Cancer Cell Int. 2018, 18, 171. https://doi.org/10.1186/s12935-018-0642-8</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Mansour, T. Hyodo, K. A. Akter, T. Kokuryo, K. Uehara, M. Nagino, T. Senga, Oncotarget 2016, 7, 4993. https://doi.org/10.18632/oncotarget.6651</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Mansour, T. Senga, Int. J. Biochem. Cell Biol. 2017, 88, 1. https://doi.org/10.1016/j.biocel.2017.04.011</Citation>
        </Reference>
        <Reference>
          <Citation>A. Roman-Fernandez, J. Roignot, E. Sandilands, M. Nacke, M. A. Mansour, L. McGarry, E. Shanks, K. E. Mostov, D. M. Bryant, Nat. Commun. 2018, 9, 5041. https://doi.org/10.1038/s41467-018-07464-8</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Mansour, E. Asano, T. Hyodo, K. A. Akter, M. Takahashi, M. Hamaguchi, T. Senga, Exp. Cell Res. 2015, 332, 78. https://doi.org/10.1016/j.yexcr.2014.12.003</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Mansour, T. Hyodo, S. Ito, K. Kurita, T. Kokuryo, K. Uehara, M. Nagino, M. Takahashi, M. Hamaguchi, T. Senga, FEBS J. 2015, 282, 1394. https://doi.org/10.1111/febs.13227</Citation>
        </Reference>
        <Reference>
          <Citation>J. X. Zhang, M. Yun, Y. Xu, J. W. Chen, H. W. Weng, Z. S. Zheng, C. Chen, D. Xie, S. Ye, Oncotarget 2016, 7, 4414. https://doi.org/10.18632/oncotarget.6780</Citation>
        </Reference>
        <Reference>
          <Citation>J. X. Zhang, S. J. Mai, X. X. Huang, F. W. Wang, Y. J. Liao, M. C. Lin, H. F. Kung, Y. X. Zeng, D. Xie, Ann. Oncol. 2014, 25, 2196. https://doi.org/10.1093/annonc/mdu439</Citation>
        </Reference>
        <Reference>
          <Citation>J. Hyle, Y. Zhang, S. Wright, B. Xu, Y. Shao, J. Easton, L. Tian, R. Feng, P. Xu, C. Li, Nucleic Acids Res. 2019, 47, 6699. https://doi.org/10.1093/nar/gkz462</Citation>
        </Reference>
        <Reference>
          <Citation>T. A. Hore, J. E. Deakin, J. A. Marshall Graves, PLoS Genet. 2008, 4, e1000169. https://doi.org/10.1371/journal.pgen.1000169</Citation>
        </Reference>
        <Reference>
          <Citation>H. Kanaizumi, C. Higashi, Y. Tanaka, M. Hamada, W. Shinzaki, T. Azumi, Y. Hashimoto, H. Inui, T. Houjou, Y. Komoike, Oncol. Lett. 2019, 17, 1962. https://doi.org/10.3892/ol.2018.9759</Citation>
        </Reference>
        <Reference>
          <Citation>H. Zhou, J. Skolnick, Biophys. J. 2009, 96, 2119. https://doi.org/10.1016/j.bpj.2008.12.3898</Citation>
        </Reference>
        <Reference>
          <Citation>J. Chen, C. Gong, H. Mao, Z. Li, Z. Fang, Q. Chen, M. Lin, X. Jiang, Y. Hu, W. Wang, X. Zhang, X. Chen, H. Li, Int. J. Oncol. 2018, 53, 567. https://doi.org/10.3892/ijo.2018.4429</Citation>
        </Reference>
        <Reference>
          <Citation>M. Malsy, B. Graf, K. Almstedt, BMC Biochem. 2019, 20, 2. https://doi.org/10.1186/s12858-019-0105-4</Citation>
        </Reference>
        <Reference>
          <Citation>X. Xu, X. Chen, M. Xu, X. Liu, B. Pan, J. Qin, T. Xu, K. Zeng, Y. Pan, B. He, H. Sun, L. Sun, S. Wang, Aging 2019, 11, 7357. https://doi.org/10.18632/aging.102214</Citation>
        </Reference>
        <Reference>
          <Citation>J. Dennig, M. Beato, G. Suske, EMBO J. 1996, 15, 5659.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Kim, G. Chadalapaka, S. O. Lee, D. Yamada, X. Sastre-Garau, P. A. Defossez, Y. Y. Park, J. S. Lee, S. Safe, Oncogene 2012, 31, 1034. https://doi.org/10.1038/onc.2011.296</Citation>
        </Reference>
        <Reference>
          <Citation>S. U. Mertens-Talcott, S. Chintharlapalli, X. Li, S. Safe, Cancer Res. 2007, 67, 11001. https://doi.org/10.1158/0008-5472.CAN-07-2416</Citation>
        </Reference>
        <Reference>
          <Citation>E. Hedrick, L. Crose, C. M. Linardic, S. Safe, Mol. Cancer Ther. 2015, 14, 2143. https://doi.org/10.1158/1535-7163.MCT-15-0148</Citation>
        </Reference>
        <Reference>
          <Citation>J. Luo, N. L. Solimini, S. J. Elledge, Cell 2009, 136, 823. https://doi.org/10.1016/j.cell.2009.02.024</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33113244</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0461</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>35</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biochemical and molecular toxicology</Title>
          <ISOAbbreviation>J Biochem Mol Toxicol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>SP3 is associated with migration, invasion, and Akt/PKB signalling in MDA-MB-231 breast cancer cells.</ArticleTitle>
        <Pagination>
          <StartPage>e22657</StartPage>
          <MedlinePgn>e22657</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jbt.22657</ELocationID>
        <Abstract>
          <AbstractText>Specificity proteins (SPs) have pro-oncogenic functions in cancer cells, ranging from cancer cell proliferation, migration, invasion, and angiogenesis. There is strong evidence that several antineoplastic drugs target depletion of SP proteins via different pathways. However, the mode of action of SP3 and the underlying consequences of its depletion are not well understood. Here, we demonstrate that SP3 is overexpressed in invasive breast cancer cells vs normal counterparts. The gene expression analysis from The Cancer Genome Atlas datasets indicated that SP3 is strongly correlated with Akt signalling-related proteins, G protein subunit alpha 13, and RAB33B (RAB33B, member RAS oncogene family). RNA interference of SP3 decreased active phosphorylation of Akt at serine and threonine sites. These findings indicate that SP3 exhibits a pro-oncogenic function, which clearly fits the description of an nononcogene addiction gene. Future analyses are prompted to uncover the SP3 gene regulation function and to reveal downstream targets of SP3 in breast cancer.</AbstractText>
          <CopyrightInformation>Â© 2020 Wiley Periodicals LLC.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mansour</LastName>
            <ForeName>Mohammed A</ForeName>
            <Initials>MA</Initials>
            <Identifier Source="ORCID">0000-0001-8701-4007</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Human Sciences, School of Applied Sciences, London South Bank University, London, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biochemistry Division, Department of Chemistry, Faculty of Science, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Biochem Mol Toxicol</MedlineTA>
        <NlmUniqueID>9717231</NlmUniqueID>
        <ISSNLinking>1095-6670</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C497121">SP3 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>148710-94-5</RegistryNumber>
          <NameOfSubstance UI="D051705">Sp3 Transcription Factor</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002465" MajorTopicYN="Y">Cell Movement</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051705" MajorTopicYN="N">Sp3 Transcription Factor</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Akt signalling</Keyword>
        <Keyword MajorTopicYN="N">GNA13</Keyword>
        <Keyword MajorTopicYN="N">SP3</Keyword>
        <Keyword MajorTopicYN="N">breast cancer</Keyword>
        <Keyword MajorTopicYN="N">transcription factor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>17</Hour>
          <Minute>19</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33113244</ArticleId>
        <ArticleId IdType="doi">10.1002/jbt.22657</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>D. L. Holliday, V. Speirs, Breast Cancer Res. 2011, 13, 215. https://doi.org/10.1186/bcr2889</Citation>
        </Reference>
        <Reference>
          <Citation>J. Liu, P. Wang, P. Zhang, X. Zhang, H. Du, Q. Liu, B. Huang, C. Qian, S. Zhang, W. Zhu, X. Yang, Y. Xiao, Z. Liu, D. Luo, J. Appl. Genet. 2019, 60, 335. https://doi.org/10.1007/s13353-019-00507-w</Citation>
        </Reference>
        <Reference>
          <Citation>Y. H. Zhou, Y. Liu, W. Zhang, C. Liu, J. J. He, X. J. Tang, Pathol., Res. Pract. 2019, 215, 152644. https://doi.org/10.1016/j.prp.2019.152644</Citation>
        </Reference>
        <Reference>
          <Citation>C. B. Moelans, J. de Ligt, P. van der Groep, P. Prins, N. Besselink, M. Hoogstraat, N. Ter Hoeve, M. Lacle, R. Kornegoor, C. van der Pol, W. de Leng, E. Barbe, B. van der Vegt, J. Martens, P. Bult, V. T. Smits, M. Koudijs, I. Nijman, E. Voest, P. Selenica, B. Weigelt, J. Reis-Filho, E. van der Wall, E. Cuppen, P. J. van Diest, Endocr.-Relat. Cancer 2019, 26, 779. https://doi.org/10.1530/ERC-19-0278</Citation>
        </Reference>
        <Reference>
          <Citation>J. Johnson, D. C. Bessette, J. M. Saunus, C. E. Smart, S. Song, R. L. Johnston, S. Cocciardi, E. N. Rozali, C. N. Johnstone, A. C. Vargas, S. H. Kazakoff, V. C. BioBank, K. K. Khanna, S. R. Lakhani, G. Chenevix-Trench, P. T. Simpson, K. Nones, N. Waddell, F. Al-Ejeh, Breast Cancer Res. Treat. 2018, 170, 179. https://doi.org/10.1007/s10549-018-4719-9</Citation>
        </Reference>
        <Reference>
          <Citation>J. Greshock, K. E. Bachman, Y. Y. Degenhardt, J. Jing, Y. H. Wen, S. Eastman, E. McNeil, C. Moy, R. Wegrzyn, K. Auger, M. A. Hardwicke, R. Wooster, Cancer Res. 2010, 70, 3677. https://doi.org/10.1158/0008-5472.CAN-09-3788</Citation>
        </Reference>
        <Reference>
          <Citation>S. Safe, J. Abbruzzese, M. Abdelrahim, E. Hedrick, Cancer Prev. Res. 2018, 11, 371. https://doi.org/10.1158/1940-6207.CAPR-17-0407</Citation>
        </Reference>
        <Reference>
          <Citation>M. Marin, A. Karis, P. Visser, F. Grosveld, S. Philipsen, Cell 1997, 89, 619. https://doi.org/10.1016/s0092-8674(00)80243-3</Citation>
        </Reference>
        <Reference>
          <Citation>C. Vizcaino, S. Mansilla, J. Portugal, Pharmacol. Ther. 2015, 152, 111. https://doi.org/10.1016/j.pharmthera.2015.05.008</Citation>
        </Reference>
        <Reference>
          <Citation>Z. Huang, L. Huang, S. Shen, J. Li, H. Lu, W. Mo, Y. Dang, D. Luo, G. Chen, Z. Feng, Oncol. Rep. 2015, 34, 2403. https://doi.org/10.3892/or.2015.4259</Citation>
        </Reference>
        <Reference>
          <Citation>E. Hedrick, Y. Cheng, U. H. Jin, K. Kim, S. Safe, Oncotarget 2016, 7, 22245. https://doi.org/10.18632/oncotarget.7925</Citation>
        </Reference>
        <Reference>
          <Citation>Y. Cheng, P. Imanirad, I. Jutooru, E. Hedrick, U. H. Jin, A. Rodrigues Hoffman, J. Leal de Araujo, B. Morpurgo, A. Golovko, S. Safe, PLoS One 2018, 13, e0192264. https://doi.org/10.1371/journal.pone.0192264</Citation>
        </Reference>
        <Reference>
          <Citation>L. Li, J. R. Davie, Ann. Anat. 2010, 192, 275. https://doi.org/10.1016/j.aanat.2010.07.010</Citation>
        </Reference>
        <Reference>
          <Citation>A. Sapetschnig, F. Koch, G. Rischitor, T. Mennenga, G. Suske, J. Biol. Chem. 2004, 279, 42095. https://doi.org/10.1074/jbc.M404989200</Citation>
        </Reference>
        <Reference>
          <Citation>X. X. Wang, G. C. Guo, X. K. Qian, D. W. Dou, Z. Zhang, X. D. Xu, X. Duan, X. H. Pei, Cancer Cell Int. 2018, 18, 171. https://doi.org/10.1186/s12935-018-0642-8</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Mansour, T. Hyodo, K. A. Akter, T. Kokuryo, K. Uehara, M. Nagino, T. Senga, Oncotarget 2016, 7, 4993. https://doi.org/10.18632/oncotarget.6651</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Mansour, T. Senga, Int. J. Biochem. Cell Biol. 2017, 88, 1. https://doi.org/10.1016/j.biocel.2017.04.011</Citation>
        </Reference>
        <Reference>
          <Citation>A. Roman-Fernandez, J. Roignot, E. Sandilands, M. Nacke, M. A. Mansour, L. McGarry, E. Shanks, K. E. Mostov, D. M. Bryant, Nat. Commun. 2018, 9, 5041. https://doi.org/10.1038/s41467-018-07464-8</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Mansour, E. Asano, T. Hyodo, K. A. Akter, M. Takahashi, M. Hamaguchi, T. Senga, Exp. Cell Res. 2015, 332, 78. https://doi.org/10.1016/j.yexcr.2014.12.003</Citation>
        </Reference>
        <Reference>
          <Citation>M. A. Mansour, T. Hyodo, S. Ito, K. Kurita, T. Kokuryo, K. Uehara, M. Nagino, M. Takahashi, M. Hamaguchi, T. Senga, FEBS J. 2015, 282, 1394. https://doi.org/10.1111/febs.13227</Citation>
        </Reference>
        <Reference>
          <Citation>J. X. Zhang, M. Yun, Y. Xu, J. W. Chen, H. W. Weng, Z. S. Zheng, C. Chen, D. Xie, S. Ye, Oncotarget 2016, 7, 4414. https://doi.org/10.18632/oncotarget.6780</Citation>
        </Reference>
        <Reference>
          <Citation>J. X. Zhang, S. J. Mai, X. X. Huang, F. W. Wang, Y. J. Liao, M. C. Lin, H. F. Kung, Y. X. Zeng, D. Xie, Ann. Oncol. 2014, 25, 2196. https://doi.org/10.1093/annonc/mdu439</Citation>
        </Reference>
        <Reference>
          <Citation>J. Hyle, Y. Zhang, S. Wright, B. Xu, Y. Shao, J. Easton, L. Tian, R. Feng, P. Xu, C. Li, Nucleic Acids Res. 2019, 47, 6699. https://doi.org/10.1093/nar/gkz462</Citation>
        </Reference>
        <Reference>
          <Citation>T. A. Hore, J. E. Deakin, J. A. Marshall Graves, PLoS Genet. 2008, 4, e1000169. https://doi.org/10.1371/journal.pgen.1000169</Citation>
        </Reference>
        <Reference>
          <Citation>H. Kanaizumi, C. Higashi, Y. Tanaka, M. Hamada, W. Shinzaki, T. Azumi, Y. Hashimoto, H. Inui, T. Houjou, Y. Komoike, Oncol. Lett. 2019, 17, 1962. https://doi.org/10.3892/ol.2018.9759</Citation>
        </Reference>
        <Reference>
          <Citation>H. Zhou, J. Skolnick, Biophys. J. 2009, 96, 2119. https://doi.org/10.1016/j.bpj.2008.12.3898</Citation>
        </Reference>
        <Reference>
          <Citation>J. Chen, C. Gong, H. Mao, Z. Li, Z. Fang, Q. Chen, M. Lin, X. Jiang, Y. Hu, W. Wang, X. Zhang, X. Chen, H. Li, Int. J. Oncol. 2018, 53, 567. https://doi.org/10.3892/ijo.2018.4429</Citation>
        </Reference>
        <Reference>
          <Citation>M. Malsy, B. Graf, K. Almstedt, BMC Biochem. 2019, 20, 2. https://doi.org/10.1186/s12858-019-0105-4</Citation>
        </Reference>
        <Reference>
          <Citation>X. Xu, X. Chen, M. Xu, X. Liu, B. Pan, J. Qin, T. Xu, K. Zeng, Y. Pan, B. He, H. Sun, L. Sun, S. Wang, Aging 2019, 11, 7357. https://doi.org/10.18632/aging.102214</Citation>
        </Reference>
        <Reference>
          <Citation>J. Dennig, M. Beato, G. Suske, EMBO J. 1996, 15, 5659.</Citation>
        </Reference>
        <Reference>
          <Citation>K. Kim, G. Chadalapaka, S. O. Lee, D. Yamada, X. Sastre-Garau, P. A. Defossez, Y. Y. Park, J. S. Lee, S. Safe, Oncogene 2012, 31, 1034. https://doi.org/10.1038/onc.2011.296</Citation>
        </Reference>
        <Reference>
          <Citation>S. U. Mertens-Talcott, S. Chintharlapalli, X. Li, S. Safe, Cancer Res. 2007, 67, 11001. https://doi.org/10.1158/0008-5472.CAN-07-2416</Citation>
        </Reference>
        <Reference>
          <Citation>E. Hedrick, L. Crose, C. M. Linardic, S. Safe, Mol. Cancer Ther. 2015, 14, 2143. https://doi.org/10.1158/1535-7163.MCT-15-0148</Citation>
        </Reference>
        <Reference>
          <Citation>J. Luo, N. L. Solimini, S. J. Elledge, Cell 2009, 136, 823. https://doi.org/10.1016/j.cell.2009.02.024</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
